Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban - Related Studies

Beta test our new site.

Home Search Study Topics Glossary

Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban

This study has been completed.

Study NCT01436526 Information provided by Bayer

First Received on September 16, 2011. Last Updated on March 21, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Interventions listed in this trial

Sponsors listed in this trial